Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic <i>Escherichia coli</i> diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa
Anu Kantele, Marianna Riekkinen, T. Sakari Jokiranta, Sari H. Pakkanen, Jukka-Pekka Pietilä, Anu Patjas +10 more
Journal of Travel Medicine
Abstract
This Phase 2b trial is the largest on ETVAX® undertaken amongst travellers to date. ETVAX® showed an excellent safety profile and proved strongly immunogenic, which encourages the further development of this vaccine.
Concepts
MedicineEnterotoxigenic Escherichia coliPlaceboImmunogenicityAdverse effectDiarrheaInternal medicineRandomized controlled trial